bpc-157 human studies randomized clinical trial safety Here's a nice graphic on that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D bpc-157 clinical humans safety – BPC‑157 Research Peptide | Genetra

..........................................1 ml

The B12 has degraded, and the tirzepatide peptide may have been affected as well

The Pure Glow Fusion is a longevity + recovery-focused peptide blend designed to support the things people usually care about most: healthier-looking skin, faster recovery, and better overall resilience

It has not been evaluated by the MHRA, the FDA, or any other regulatory authority for safety or efficacy in any application

has received consulting fees from Abbott, AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pendopharm, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Shire, Sublimity Therapeutics and Takeda